This study was conducted to determine whether nature-derived
Reynoutria elliptica extracts exhibit biocompatibility and antimicrobial effects against oral pathogens such as
Streptococcus mutans and
Candida albicans. Fine particles of
Reynoutria elliptica extract were used to probe for biocompatibility and antimicrobial activity toward these pathogens
, and results were evaluated with an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay, spectrophotometric growth inhibitory assay, the total number of colony-forming units (CFU), an agar disk diffusion test, and scanning electron microscopy (SEM). In addition, UV/VIS spectroscopy was used to determine the levels of flavonoid and polyphenol in experimental solutions. Several experimental groups showed cell viability higher than 70%, and the antimicrobial activity toward both
S. mutans and
C. albicans was significantly higher than was that seen for the control group. In CFU and agar disk diffusion tests with
C. albicans, increases in the concentration of
Reynoutria elliptica extract led to significantly increased antimicrobial effects. Additionally, SEM results showed that
Reynoutria elliptica extract changed the morphology and density of
S. mutans and
C. albicans. The results of this research can be applied to the use of
Reynoutria elliptica extracts for the development of oral products that are biologically friendly and can control oral diseases such as dental caries and candida-associated denture stomatitis.
View Full-Text
►▼
Show Figures
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited